While AMGEN Inc has underperformed by -3.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMGN fell by -7.51%, with highs and lows ranging from $346.85 to $253.30, whereas the simple moving average fell by -2.37% in the last 200 days.
On December 10, 2024, BofA Securities started tracking AMGEN Inc (NASDAQ: AMGN) recommending Underperform. A report published by Wolfe Research on November 15, 2024, Initiated its previous ‘Peer Perform’ rating for AMGN. Citigroup also rated AMGN shares as ‘Neutral’, setting a target price of $335 on the company’s shares in an initiating report dated November 14, 2024. Bernstein Initiated an Outperform rating on October 17, 2024, and assigned a price target of $380. Truist October 14, 2024d its ‘Buy’ rating to ‘Hold’ for AMGN, as published in its report on October 14, 2024. Cantor Fitzgerald’s report from September 27, 2024 suggests a price prediction of $405 for AMGN shares, giving the stock a ‘Overweight’ rating. Wells Fargo also rated the stock as ‘Equal Weight’.
Analysis of AMGEN Inc (AMGN)
It’s important to note that AMGN shareholders are currently getting $9.00 per share in dividends, so investors will receive a return regardless of how the company performs. Further, the quarter-over-quarter increase in sales is 11.66%, showing a positive trend in the upcoming months.
AMGEN Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of 67.55% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.95, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and AMGN is registering an average volume of 3.85M. On a monthly basis, the volatility of the stock is set at 2.24%, whereas on a weekly basis, it is put at 3.31%, with a gain of 4.84% over the past seven days. Furthermore, long-term investors anticipate a median target price of $316.38, showing growth from the present price of $297.78, which can serve as yet another indication of whether AMGN is worth investing in or should be passed over.
How Do You Analyze AMGEN Inc Shares?
A giant in the Drug Manufacturers – General market, AMGEN Inc (AMGN) is based in the USA. When comparing AMGEN Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 39.44, there is a growth in quarterly earnings of -18.33%.
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.24%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 77.66% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
AMGN shares are owned by institutional investors to the tune of 77.66% at present.
